Nantahala Capital Management »

Amneal Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 2.7M 6.35
2024-03-31 $16M 2.6M 6.06
2023-12-31 $14M 2.3M 6.07
2023-09-30 $9.3M 2.2M 4.22
2023-06-30 $6.7M 2.1M 3.10
2023-03-31 $695k 500k 1.39

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Amneal Pharmaceuticals

Vanguard Group
Tpg Gp A
BlackRock
Rubric Capital Management
Citadel Advisors
Fosun International
Dimensional Fund Advisors
Neuberger Berman Group
Geode Capital Management
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Hennessy Advisors
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals